Drug Delivery Devices Companies
1-20 of 64 results
Accellent Inc. (Accellent) is a medical device company engaged in the design, development and engineering, precision component manufacturing, device assembly and supply chain management services. The company provides outsourced precision manufacturing and engineering services in Cardiology, Orthopedics, Drug Delivery, Endoscopy and Neurology markets of the medical device industry. It operates in the US, Ireland, Germany, Sweden, Netherlands, Other Western Europe, the UK, France, Asia Pacific and Eastern Europe. The company is a wholly owned subsidiary of Accellent Holdings Corp. In 2005, the company was as a result of merger with Accellent Merger Sub Inc., a wholly-owned subsidiary of Accellent Acquisition Corp. (AAC). It is headquartered in Massachusetts, the US.
The company reported revenues of (U.S. Dollars) USD 525.47 million during the fiscal year ended December 2008, an increase of 11.4% over 2007. The operating profit of the company was USD 59.44 million during the fiscal year 2008, as increase of 129.62% over 2007. The net loss of the company was USD 13.31 million during the fiscal year 2008, as compared to a net loss of USD 274.88 million during 2007.
Specialty Devices > Drug Delivery Devices > Companies Acrux Limited is an innovative Australian drug delivery Company. The company focuses in developing and commercialising a range of patient-preferred, patented products for global markets, using unique technology to administer drugs through the skin. The company's proprietary Metered Dose Transdermal System (MDTS) is used for transdermal drug delivery. The product protfolio includes three products such as Estradiol MDTS, Testosterone MDTS and Testosterone MD. It is headquartered in West Melbourne, Australia and employs 43 people.
Specialty Devices > Drug Delivery Devices > Companies Acusphere, Inc. is a pharmaceutical company that develops new drugs and improved formulations of existing drugs using its porous microparticle technology. The company is located at Tewksbury, the US.
Specialty Devices > Drug Delivery Devices > Companies Akela Pharma Inc., (Akela) is an integrated product development company focused on developing drug delivery technologies and therapeutics for the pain market. It also provides research and development services including specialty drug manufacturing, product development & testing, analytical method development and patent litigation support services. Taifuno is the company’s Inhalation Drug Delivery Platform. The company's lead product, Fentanyl TAIFUN is under development is for the treatment of breakthrough cancer pain. It is a fast-acting fentanyl formulation, delivered using the company’s approved TAIFUN dry powder inhaler platform. Other products under development include Akela CGRP for Asthma, Akela GHRH for Growth hormone secretion, and Akela EDACS, CureCap for Drug Abuse. It is headquartered in Quebec, Canada. In May 2009, it completed the acquisition of Nventa Biopharmaceuticals Corporation. In March 2009, Akela settled the outstanding litigation with LAB Research Inc. Earlier in January, Akela reported that it had reached the third milestone in a series of three Fentanyl Taifun Phase 3 study related milestones to be paid by Janssen Pharmaceutica NV. In February, the company reported that its PharmaForm subsidiary signed an agreement with a global pharmaceutical company to develop specialized oral dosage forms.
Specialty Devices > Drug Delivery Devices > Companies Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of products for the treatment of acute and intermittent conditions. The Company has six product candidates in clinical development. Its technology, the Staccato system, vaporizes excipient-free drugs to form condensation aerosols that, when inhaled, allows for rapid systemic drug delivery. The company is located in Mountain View, United States.
Specialty Devices > Drug Delivery Devices > Companies Alkermes, Inc., (Alkermes) a biotechnology company that develops and manufactures extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction, and diabetes. The company mainly manufactures RISPERDAL CONSTA for schizophrenia and also manufactures and developed VIVITROL for alcohol dependence. It also has other products in the development stage such as Exenatide Once Weekly, VIVITROL for opiod, ALKS 29, ALKS 27 and ALKS 33. It was founded in 1987. The company has its operations in the UK and the US. Alkermes is headquartered in Massachusetts, the US.
Specialty Devices > Drug Delivery Devices > Companies Analytica Limited (Analytica) is a medical device company, engaged in the development and manufacture of Constant Flow Device and retractable technology. The company has formed a joint venture, Analytica Lingyang Limited with J & J Stamina Enterprises Ltd, Taiwan and Zhejiang Lingyang Medical Apparatus Co. Ltd., China to produce retractable technology products. The company is headquartered in Australia.
Specialty Devices > Drug Delivery Devices > Companies Anesiva, Inc. is a biopharmaceutical company based in South San Francisco,United States. Anesiva is focused on the development and commercialization of therapeutic treatments for pain management. Its portfolio of products includes Zingo powder intradermal injection system and Adlea, which is a long-acting, site-specific, non-opioid analgesic, being developed for moderate to severe pain.
Specialty Devices > Drug Delivery Devices > Companies Antares Pharma, Inc. (Antares Pharma) is a leading developer and marketer of parenteral pharmaceutical products. The company focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. Its subcutaneous injection technology platforms include Vision, reusable needle-free injectors; Vibex, disposable pressure-assisted auto injectors; and disposable multi-use pen injectors. Antares Pharma maintains partnerships with various companies to develop products. In Injector area, the company has multi-product deal with Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. Also, the company has partnership with BioSante Pharmaceuticals, Inc., which includes LibiGel (transdermal testosterone gel) in Phase 3 clinical development for the treatment of female sexual dysfunction. The company’s parenteral products division is located in Minneapolis, Minnesota. Antares Pharma is headquartered in Ewing, New Jersey, the US.
Specialty Devices > Drug Delivery Devices > Companies Apogee Technology, Inc. (Apogee) is involved in the design, development and marketing of medical devices and proprietary sensor products for the markets such as medical, industrial, consumer and automotive. Presently, the company is developing a medical device based on MEMS technology for transdermal drug delivery. The company is headquartered in Massachusetts, United States and employs 14 people.
Specialty Devices > Drug Delivery Devices > Companies Aradigm Corporation (Aradigm) is a specialty pharmaceutical company, engaged in the development and commercialization of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The company principally operates in the Unites States. It is headquartered in Hayward, California, United States and employs 38 people.
Specialty Devices > Drug Delivery Devices > Companies Auxilium Pharmaceuticals, Inc. (Auxilium) is a specialty biopharmaceutical company in the US. It focuses on the development and marketing of products for the treatment of urology and sexual health problems. The company primarily markets its products to urologists, endocrinologists, orthopedists, general and plastic surgeons, and select primary care physicians. It markets Testim, a proprietary, topical 1% testosterone once-a-day gel for the treatment of hypogonadism in men and XIAFLEX, for the treatment of Dupuytren's Contracture. Auxilium’s XIAFLEX is also used for the treatment of Peyronie's disease and Frozen shoulder syndrome, therapy. The company has partnership with Pfizer Inc. (Pfizer) to develop and market its XIAPEX for Dupuytren’s and Peyronie’s disease in Europe and certain Eurasian countries. Auxilium is headquartered in Pennsylvania, the US.
Specialty Devices > Drug Delivery Devices > Companies Becton, Dickinson and Company (BD) is a medical technology company serving large healthcare institutions, life science researchers and clinical laboratories. The company is involved in manufacturing and selling of medical supplies and devices, laboratory equipment and diagnostic products. The company operates in the U.S., Canada, Europe, Middle East, Africa, Japan, Asia Pacific, and Latin America. It is headquartered in New Jersey, United States. BD operates through three reportable business segments namely: Medical (53.1% of the total revenues during fiscal year 2008), Diagnostics (30.2%) and Biosciences (16.7%). The company classifies its geographic locations into three regions namely, United States Europe and Other operations. The United States region accounted for 44.5% of the total revenues of the company for the fiscal year 2008 followed by Europe (34.8%) and Other operations (20.7%).
Specialty Devices > Drug Delivery Devices > Companies Biocompatibles International is a medical technology company which focuses on drug device combination products which are used in cardiology and oncology. The company is headquartered in Surrey, the UK.
Specialty Devices > Drug Delivery Devices > Companies Bioject Medical Technologies, Inc. (Bioject) is a medical device company involved in developing the world's leading technology for needle-free injection of liquid medications. The company’s systems are designed to deliver injected medications comfortably, accurately, and quickly without using a needle. It is headquartered in Oregon, the United States. Bioject generates its revenues through a single reportable business segment namely, the development of needle-free injection systems. This segment is further categorized into three product lines: Biojector 2000 (representing 14.61% of the company’s product revenues during fiscal year 2008), Spring Powered (75.57%) and Vial Adapters (9.81%). The company classifies its geographic locations into two regions namely, United States and All Other. The United States region accounted for 70.31% of the total revenues of the company for the fiscal year 2008 followed by All Other (29.69%). In February 2009, the company extended its supply agreement with Ferring Pharmaceuticals, Inc., for the sale of its needle-free drug vial adapters. Also in February 2009, the company entered into agreement with International AIDS Vaccine Initiative (IAVI) to supply its unique Needle-Free Injection Therapy (NFIT) system, the Biojector 2000.
Specialty Devices > Drug Delivery Devices > Companies Codman & Shurtleff, Inc. develops and markets a wide range of diagnostic and therapeutic products for the treatment of central nervous system disorders. Codman focus is on Intractable Pain Management, Pediatric & Adult Hydrocephalus, and Neuro Critical Care. The company's product line includes Drug Pumps, Cerebrospinal Fluid Shunts, Advanced Neuro-Monitoring, and Electrosurgical Systems. The company is headquartered in Raynham, United States.
Specialty Devices > Drug Delivery Devices > Companies Consort Medical plc (Consort Medical), formerly known as Bespak plc is involved in designing, developing and manufacturing of specialty medical devices and services for the pharmaceutical industry. It is also a major supplier of drug delivery technologies and services to the pharmaceutical, drug delivery and biotechnology industries. The company is headquartered Hemel Hempstead, England, the UK. According to its strategy, the company intended to focus on medical devices, hence sold its Consumer Dispensers business and later changed its name to Consort Medical plc. The company would operate the Inhaled Drug Delivery business segment under the Consort Medical brand and Anaesthesia business segment under the King Systems brand. Consort Medical generates revenues through two business segments, namely, Inhaled Drug Delivery (74.8% of its total revenues during the fiscal year 2008) and Anaesthesia (25.2%). On September 24, 2009, the company acquired all the outstanding shares of The Medical House PLC, a UK-based medical device company, for a purchase consideration of approximately $27.05 million. The acquisition will enable Consort Medical to improve its existing position as a global supplier of drug delivery device and airway management product technologies.
Specialty Devices > Drug Delivery Devices > Companies Corium International, Inc. develops, engineers, and manufactures drug delivery products and devices that utilize the skin and mucosa as a primary means of transport. The company is headquartered in Menlo Park, California, the US.
Specialty Devices > Drug Delivery Devices > Companies CytoCore, Inc. (CytoCore) is a life sciences company involved in the design, development and commercialization of cost-effective screening systems for the early detection of cancer. The company is headquartered in Illinois, United States and employs nine people.
Specialty Devices > Drug Delivery Devices > Companies Debiotech S.A. is a medical technology company. The company focuses on the development of highly innovative medical devices for therapeutic and diagnostic purposes through drug delivery sysytems. Disposable programmable micropumps, miniaturized infusion pumps, contrast media injectors, drug reconstitution devices, cycler for peritoneal dialysis, flow regulators, nano delivery systems are the products of the company. It performs research and development of the products based on the technologies such as microtechnology, micromechanics and microelectronics. The company is headquartered in Lausanne, Switzerland.
Specialty Devices > Drug Delivery Devices > Companies See all Companies
Specialty Devices > Drug Delivery Devices > Companies Acrux Limited is an innovative Australian drug delivery Company. The company focuses in developing and commercialising a range of patient-preferred, patented products for global markets, using unique technology to administer drugs through the skin. The company's proprietary Metered Dose Transdermal System (MDTS) is used for transdermal drug delivery. The product protfolio includes three products such as Estradiol MDTS, Testosterone MDTS and Testosterone MD. It is headquartered in West Melbourne, Australia and employs 43 people.
Specialty Devices > Drug Delivery Devices > Companies Acusphere, Inc. is a pharmaceutical company that develops new drugs and improved formulations of existing drugs using its porous microparticle technology. The company is located at Tewksbury, the US.
Specialty Devices > Drug Delivery Devices > Companies Akela Pharma Inc., (Akela) is an integrated product development company focused on developing drug delivery technologies and therapeutics for the pain market. It also provides research and development services including specialty drug manufacturing, product development & testing, analytical method development and patent litigation support services. Taifuno is the company’s Inhalation Drug Delivery Platform. The company's lead product, Fentanyl TAIFUN is under development is for the treatment of breakthrough cancer pain. It is a fast-acting fentanyl formulation, delivered using the company’s approved TAIFUN dry powder inhaler platform. Other products under development include Akela CGRP for Asthma, Akela GHRH for Growth hormone secretion, and Akela EDACS, CureCap for Drug Abuse. It is headquartered in Quebec, Canada. In May 2009, it completed the acquisition of Nventa Biopharmaceuticals Corporation. In March 2009, Akela settled the outstanding litigation with LAB Research Inc. Earlier in January, Akela reported that it had reached the third milestone in a series of three Fentanyl Taifun Phase 3 study related milestones to be paid by Janssen Pharmaceutica NV. In February, the company reported that its PharmaForm subsidiary signed an agreement with a global pharmaceutical company to develop specialized oral dosage forms.
Specialty Devices > Drug Delivery Devices > Companies Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of products for the treatment of acute and intermittent conditions. The Company has six product candidates in clinical development. Its technology, the Staccato system, vaporizes excipient-free drugs to form condensation aerosols that, when inhaled, allows for rapid systemic drug delivery. The company is located in Mountain View, United States.
Specialty Devices > Drug Delivery Devices > Companies Alkermes, Inc., (Alkermes) a biotechnology company that develops and manufactures extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction, and diabetes. The company mainly manufactures RISPERDAL CONSTA for schizophrenia and also manufactures and developed VIVITROL for alcohol dependence. It also has other products in the development stage such as Exenatide Once Weekly, VIVITROL for opiod, ALKS 29, ALKS 27 and ALKS 33. It was founded in 1987. The company has its operations in the UK and the US. Alkermes is headquartered in Massachusetts, the US.
Specialty Devices > Drug Delivery Devices > Companies Analytica Limited (Analytica) is a medical device company, engaged in the development and manufacture of Constant Flow Device and retractable technology. The company has formed a joint venture, Analytica Lingyang Limited with J & J Stamina Enterprises Ltd, Taiwan and Zhejiang Lingyang Medical Apparatus Co. Ltd., China to produce retractable technology products. The company is headquartered in Australia.
Specialty Devices > Drug Delivery Devices > Companies Anesiva, Inc. is a biopharmaceutical company based in South San Francisco,United States. Anesiva is focused on the development and commercialization of therapeutic treatments for pain management. Its portfolio of products includes Zingo powder intradermal injection system and Adlea, which is a long-acting, site-specific, non-opioid analgesic, being developed for moderate to severe pain.
Specialty Devices > Drug Delivery Devices > Companies Antares Pharma, Inc. (Antares Pharma) is a leading developer and marketer of parenteral pharmaceutical products. The company focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. Its subcutaneous injection technology platforms include Vision, reusable needle-free injectors; Vibex, disposable pressure-assisted auto injectors; and disposable multi-use pen injectors. Antares Pharma maintains partnerships with various companies to develop products. In Injector area, the company has multi-product deal with Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. Also, the company has partnership with BioSante Pharmaceuticals, Inc., which includes LibiGel (transdermal testosterone gel) in Phase 3 clinical development for the treatment of female sexual dysfunction. The company’s parenteral products division is located in Minneapolis, Minnesota. Antares Pharma is headquartered in Ewing, New Jersey, the US.
Specialty Devices > Drug Delivery Devices > Companies Apogee Technology, Inc. (Apogee) is involved in the design, development and marketing of medical devices and proprietary sensor products for the markets such as medical, industrial, consumer and automotive. Presently, the company is developing a medical device based on MEMS technology for transdermal drug delivery. The company is headquartered in Massachusetts, United States and employs 14 people.
Specialty Devices > Drug Delivery Devices > Companies Aradigm Corporation (Aradigm) is a specialty pharmaceutical company, engaged in the development and commercialization of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The company principally operates in the Unites States. It is headquartered in Hayward, California, United States and employs 38 people.
Specialty Devices > Drug Delivery Devices > Companies Auxilium Pharmaceuticals, Inc. (Auxilium) is a specialty biopharmaceutical company in the US. It focuses on the development and marketing of products for the treatment of urology and sexual health problems. The company primarily markets its products to urologists, endocrinologists, orthopedists, general and plastic surgeons, and select primary care physicians. It markets Testim, a proprietary, topical 1% testosterone once-a-day gel for the treatment of hypogonadism in men and XIAFLEX, for the treatment of Dupuytren's Contracture. Auxilium’s XIAFLEX is also used for the treatment of Peyronie's disease and Frozen shoulder syndrome, therapy. The company has partnership with Pfizer Inc. (Pfizer) to develop and market its XIAPEX for Dupuytren’s and Peyronie’s disease in Europe and certain Eurasian countries. Auxilium is headquartered in Pennsylvania, the US.
Specialty Devices > Drug Delivery Devices > Companies Becton, Dickinson and Company (BD) is a medical technology company serving large healthcare institutions, life science researchers and clinical laboratories. The company is involved in manufacturing and selling of medical supplies and devices, laboratory equipment and diagnostic products. The company operates in the U.S., Canada, Europe, Middle East, Africa, Japan, Asia Pacific, and Latin America. It is headquartered in New Jersey, United States. BD operates through three reportable business segments namely: Medical (53.1% of the total revenues during fiscal year 2008), Diagnostics (30.2%) and Biosciences (16.7%). The company classifies its geographic locations into three regions namely, United States Europe and Other operations. The United States region accounted for 44.5% of the total revenues of the company for the fiscal year 2008 followed by Europe (34.8%) and Other operations (20.7%).
Specialty Devices > Drug Delivery Devices > Companies Biocompatibles International is a medical technology company which focuses on drug device combination products which are used in cardiology and oncology. The company is headquartered in Surrey, the UK.
Specialty Devices > Drug Delivery Devices > Companies Bioject Medical Technologies, Inc. (Bioject) is a medical device company involved in developing the world's leading technology for needle-free injection of liquid medications. The company’s systems are designed to deliver injected medications comfortably, accurately, and quickly without using a needle. It is headquartered in Oregon, the United States. Bioject generates its revenues through a single reportable business segment namely, the development of needle-free injection systems. This segment is further categorized into three product lines: Biojector 2000 (representing 14.61% of the company’s product revenues during fiscal year 2008), Spring Powered (75.57%) and Vial Adapters (9.81%). The company classifies its geographic locations into two regions namely, United States and All Other. The United States region accounted for 70.31% of the total revenues of the company for the fiscal year 2008 followed by All Other (29.69%). In February 2009, the company extended its supply agreement with Ferring Pharmaceuticals, Inc., for the sale of its needle-free drug vial adapters. Also in February 2009, the company entered into agreement with International AIDS Vaccine Initiative (IAVI) to supply its unique Needle-Free Injection Therapy (NFIT) system, the Biojector 2000.
Specialty Devices > Drug Delivery Devices > Companies Codman & Shurtleff, Inc. develops and markets a wide range of diagnostic and therapeutic products for the treatment of central nervous system disorders. Codman focus is on Intractable Pain Management, Pediatric & Adult Hydrocephalus, and Neuro Critical Care. The company's product line includes Drug Pumps, Cerebrospinal Fluid Shunts, Advanced Neuro-Monitoring, and Electrosurgical Systems. The company is headquartered in Raynham, United States.
Specialty Devices > Drug Delivery Devices > Companies Consort Medical plc (Consort Medical), formerly known as Bespak plc is involved in designing, developing and manufacturing of specialty medical devices and services for the pharmaceutical industry. It is also a major supplier of drug delivery technologies and services to the pharmaceutical, drug delivery and biotechnology industries. The company is headquartered Hemel Hempstead, England, the UK. According to its strategy, the company intended to focus on medical devices, hence sold its Consumer Dispensers business and later changed its name to Consort Medical plc. The company would operate the Inhaled Drug Delivery business segment under the Consort Medical brand and Anaesthesia business segment under the King Systems brand. Consort Medical generates revenues through two business segments, namely, Inhaled Drug Delivery (74.8% of its total revenues during the fiscal year 2008) and Anaesthesia (25.2%). On September 24, 2009, the company acquired all the outstanding shares of The Medical House PLC, a UK-based medical device company, for a purchase consideration of approximately $27.05 million. The acquisition will enable Consort Medical to improve its existing position as a global supplier of drug delivery device and airway management product technologies.
Specialty Devices > Drug Delivery Devices > Companies Corium International, Inc. develops, engineers, and manufactures drug delivery products and devices that utilize the skin and mucosa as a primary means of transport. The company is headquartered in Menlo Park, California, the US.
Specialty Devices > Drug Delivery Devices > Companies CytoCore, Inc. (CytoCore) is a life sciences company involved in the design, development and commercialization of cost-effective screening systems for the early detection of cancer. The company is headquartered in Illinois, United States and employs nine people.
Specialty Devices > Drug Delivery Devices > Companies Debiotech S.A. is a medical technology company. The company focuses on the development of highly innovative medical devices for therapeutic and diagnostic purposes through drug delivery sysytems. Disposable programmable micropumps, miniaturized infusion pumps, contrast media injectors, drug reconstitution devices, cycler for peritoneal dialysis, flow regulators, nano delivery systems are the products of the company. It performs research and development of the products based on the technologies such as microtechnology, micromechanics and microelectronics. The company is headquartered in Lausanne, Switzerland.
Specialty Devices > Drug Delivery Devices > Companies See all Companies
